Literature DB >> 30909217

Cognitive Resilience to Alzheimer's Disease Pathology in the Human Brain.

Erin J Aiello Bowles1, Paul K Crane2, Rod L Walker1, Jessica Chubak1,3, Andrea Z LaCroix1,4, Melissa L Anderson1, Dori Rosenberg1, C Dirk Keene5, Eric B Larson1,2.   

Abstract

BACKGROUND: Past research has focused on risk factors for developing dementia, with increasing recognition of "resilient" people who live to old age with intact cognitive function despite pathological features of Alzheimer's disease (AD).
OBJECTIVE: To evaluate demographic factors, mid-life characteristics, and non-AD neuropathology findings that may be associated with cognitive resilience to AD pathology.
METHODS: We analyzed data from 276 autopsy cases with intermediate or high levels of AD pathology from the Adult Changes in Thought study. We defined cognitive resilience as having Cognitive Abilities Screening Instrument scores ≥86 within two years of death and no clinical dementia diagnosis; non-resilient people had dementia diagnoses from AD or other causes before death. We compared mid-life characteristics, demographics, and additional neuropathology findings between resilient and non-resilient people. We used multivariable logistic regression to estimate odds ratios (ORs) with 95% confidence intervals (CIs) for being resilient compared to not being resilient adjusting for demographic and neuropathology factors.
RESULTS: We classified 68 (25%) people as resilient and 208 (75%) as not resilient. A greater proportion of resilient people had a college degree (50%) compared with non-resilient (32%, p = 0.01). The odds of being resilient were significantly increased among people with a college education (OR = 2.01, 95% CI = 1.01-3.99) and significantly reduced among people with additional non-AD neuropathology findings such as hippocampal sclerosis (OR = 0.28, 95% CI = 0.09-0.89) and microinfarcts (OR = 0.34, 95% CI = 0.15-0.78).
CONCLUSION: Increased education and absence of non-AD pathology may be independently associated with cognitive resilience, highlighting the importance of evaluating co-morbid factors in future research on mechanisms of cognitive resilience.

Entities:  

Keywords:  Aging; Alzheimer’s disease; cognition; dementia; education; neuropathology

Mesh:

Year:  2019        PMID: 30909217     DOI: 10.3233/JAD-180942

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  10 in total

1.  Cognitive reserve and rate of change in Alzheimer's and cerebrovascular disease biomarkers among cognitively normal individuals.

Authors:  Corinne Pettigrew; Anja Soldan; Yuxin Zhu; Qing Cai; Mei-Cheng Wang; Abhay Moghekar; Michael I Miller; Baljeet Singh; Oliver Martinez; Evan Fletcher; Charles DeCarli; Marilyn Albert
Journal:  Neurobiol Aging       Date:  2019-12-17       Impact factor: 4.673

2.  Retinal Biomarkers of Alzheimer Disease.

Authors:  Cecilia S Lee; Rajendra S Apte
Journal:  Am J Ophthalmol       Date:  2020-05-06       Impact factor: 5.258

3.  Investigating Predictors of Preserved Cognitive Function in Older Women Using Machine Learning: Women's Health Initiative Memory Study.

Authors:  Ramon Casanova; Sarah A Gaussoin; Robert Wallace; Laura D Baker; Jiu-Chiuan Chen; JoAnn E Manson; Victor W Henderson; Bonnie C Sachs; Jamie N Justice; Eric A Whitsel; Kathleen M Hayden; Stephen R Rapp
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

4.  Association of Cognition and Dementia With Neuropathologic Changes of Alzheimer Disease and Other Conditions in the Oldest-Old.

Authors:  Thomas J Montine; Maria M Corrada; Claudia Kawas; Syed Bukhari; Lon White; Lu Tian; Brenna Cholerton
Journal:  Neurology       Date:  2022-06-15       Impact factor: 11.800

5.  Alzheimer's Disease-Related Neuropathology Among Patients with Medication Treated Type 2 Diabetes in a Community-Based Autopsy Cohort.

Authors:  Douglas Barthold; Laura E Gibbons; Zachary A Marcum; Shelly L Gray; C Dirk Keene; Thomas J Grabowski; Nadia Postupna; Eric B Larson; Paul K Crane
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

6.  Posterior cortical atrophy phenotypic heterogeneity revealed by decoding 18F-FDG-PET.

Authors:  Ryan A Townley; Hugo Botha; Jonathan Graff-Radford; Jennifer Whitwell; Bradley F Boeve; Mary M Machulda; Julie A Fields; Daniel A Drubach; Rodolfo Savica; Ronald C Petersen; Matthew L Senjem; David S Knopman; Val J Lowe; Clifford R Jack; Keith A Josephs; David T Jones
Journal:  Brain Commun       Date:  2021-08-19

7.  Differential protein expression in the hippocampi of resilient individuals identified by digital spatial profiling.

Authors:  Jamie M Walker; Shiva Kazempour Dehkordi; Habil Zare; Miranda E Orr; Anna Fracassi; Alison Vanschoiack; Anna Pavenko; Giulio Taglialatela; Randall Woltjer; Timothy E Richardson
Journal:  Acta Neuropathol Commun       Date:  2022-02-14       Impact factor: 7.801

Review 8.  Exosomes in Age-Related Cognitive Decline: Mechanistic Insights and Improving Outcomes.

Authors:  Michael R Duggan; Anne Lu; Thomas C Foster; Mathieu Wimmer; Vinay Parikh
Journal:  Front Aging Neurosci       Date:  2022-03-01       Impact factor: 5.750

9.  The effect of college degree attainment on neurodegenerative symptoms in genetically at-risk women.

Authors:  Jinkuk Hong; Robert S Dembo; Leann Smith DaWalt; Murray Brilliant; Elizabeth M Berry-Kravis; Marsha Mailick
Journal:  SSM Popul Health       Date:  2022-10-05

10.  Application of deep learning to understand resilience to Alzheimer's disease pathology.

Authors:  Cecilia S Lee; Caitlin S Latimer; Jonathan C Henriksen; Marian Blazes; Eric B Larson; Paul K Crane; C Dirk Keene; Aaron Y Lee
Journal:  Brain Pathol       Date:  2021-05-19       Impact factor: 6.508

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.